WD Rutherford LLC Cuts Stake in GE HealthCare Technologies Inc. $GEHC

WD Rutherford LLC lowered its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 68.5% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 6,495 shares of the company’s stock after selling 14,097 shares during the quarter. WD Rutherford LLC’s holdings in GE HealthCare Technologies were worth $533,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of GEHC. Empowered Funds LLC raised its position in GE HealthCare Technologies by 6.1% during the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after buying an additional 1,665 shares during the last quarter. Acadian Asset Management LLC purchased a new position in GE HealthCare Technologies during the 1st quarter worth $259,000. Cresset Asset Management LLC raised its position in GE HealthCare Technologies by 12.5% during the 2nd quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock worth $578,000 after buying an additional 865 shares during the last quarter. Jump Financial LLC raised its position in GE HealthCare Technologies by 317.6% during the 2nd quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock worth $2,084,000 after buying an additional 21,396 shares during the last quarter. Finally, Gamco Investors INC. ET AL grew its stake in shares of GE HealthCare Technologies by 8.6% during the 2nd quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock worth $299,000 after purchasing an additional 320 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

GEHC has been the topic of a number of recent analyst reports. Stifel Nicolaus set a $80.00 price target on shares of GE HealthCare Technologies in a research note on Wednesday, April 29th. Weiss Ratings cut shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday. BTIG Research lowered their price target on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. Rothschild & Co Redburn lowered their price target on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research note on Thursday, April 30th. Finally, Morgan Stanley upped their price target on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 4th. Eight analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $80.67.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $60.76 on Monday. The stock has a market cap of $27.64 billion, a price-to-earnings ratio of 14.54, a PEG ratio of 1.37 and a beta of 0.74. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The company’s 50-day moving average price is $69.58 and its 200 day moving average price is $76.72. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. GE HealthCare Technologies’s revenue was up 7.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, research analysts forecast that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

Insider Transactions at GE HealthCare Technologies

In other news, CFO James Saccaro bought 3,310 shares of GE HealthCare Technologies stock in a transaction on Friday, May 1st. The shares were bought at an average cost of $60.60 per share, for a total transaction of $200,586.00. Following the acquisition, the chief financial officer owned 87,471 shares in the company, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Rodney F. Hochman bought 1,618 shares of GE HealthCare Technologies stock in a transaction on Tuesday, May 12th. The stock was purchased at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the acquisition, the director owned 1,618 shares in the company, valued at $100,364.54. This represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 11,847 shares of company stock worth $719,555 in the last 90 days. Insiders own 0.36% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.